Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Share-Based Payment Transactions (Tables)

v3.20.1
Share-Based Payment Transactions (Tables)
12 Months Ended
Dec. 31, 2019
Share-based Payment Arrangement [Abstract]  
Schedule of expenses
  Year ended December 31,  
    2019     2018     2017  
    USD  
                   
Research and development expenses   $ 138     $ 123     $ 139  
General and administrative expenses     132       130       53  
                         
    $ 270     $ 253     $ 192  
Schedule of share options granted was estimated using the binomial option pricing model using the following range assumptions

Description   2019  
       
Risk-free interest rate     1.19 - 2.40 %
Expected volatility     65.63 - 75.86 %
Dividend yield     0  
Contractual life     9.83 - 10  
Early Exercise Multiple (Suboptimal Factor)     2.5 - 3  
Exercise price (NIS)     0.28 - 2.344  
Schedule of number of share options, their weighted average exercise prices and modification in option plans of employees, directors and consultants
  Shares subject to options outstanding  
    2019     2018     2017  
    Number    

Weighted

average

exercise

price

    Number    

Weighted

average

exercise

price

    Number    

Weighted

average

exercise

price

 
          USD           USD           USD  
Outstanding at beginning of year     1,437,400       1.20       1,490,423       1.35       737,028       2.63  
Grants     1,240,000       0.44       -       -       970,000       0.75  
Forfeited/expired     (4,000 )     5.98       (53,023 )     7.53       (216,605 )     4.26  
                                                 
Outstanding at end of year     2,673,400       0.89       1,437,400       1.20       1,490,423       1.35  
                                                 
Exercisable at end of year     1,134,653       1.39       736,155       2.41       451,266       2.41